The US Navy seeks a commercial development partner for a personal fall arrest system for use in D-holes commonly found in ship tanks.
You are here
Medical & Biotechnology
The US Naval Air Warfare Center seeks a partner to license and commercialize a medical imaging technology that provides high resolution images at a relatively low cost.
The US Army seeks to commercialize through licensing a straightforward, effective, universal exogenous internal positive control (UEIPC) for monitoring inhibitors of PCR. This versatile innovation allows for confirmation of negative results as a true negative. It is most suitable for Taqman® based assays. The Joint Program Executive Office of the Department of Defense has chosen this as the solution for its internal positive control.
The US Naval Air Warfare Center Aircraft Division (NAVAIR) seeks licensees to commercialize a unique formulation and kit to address mildew and fungal growth without causing corrosive damage to the cleaning surface.
The US Army seeks to commercialize through patent licensing an innovative arterial catheter design that improves safety, reliability and accuracy.
The US Army seeks a commercial and/or cooperative development partner for a rapid clotting technology for use in a variety of emergency and surgical situations.
The Naval Research Laboratory (NRL) seeks to commercialize through patent licensing a method for rapidly depositing patterns of active biomolecules and living cells utilizing a focused laser pulse onto various surfaces that could be used, for example, to fabricate protein arrays for proteomics analysis.
The US Navy seeks to commercialize through patent licensing a method for measuring stress biomarkers such as cortisol in saliva by fluorescence polarization. To complement this method, the Navy is developing a hand-held fluorescence polarimeter (FP) and related rapid tests.
The Naval Medical Research Center (NMRC) seeks to commercialize through patent licensing a prophylactic treatment (before infection) for diarrhea caused by ETEC. ETEC is commonly referred to as Travelers’ Diarrhea which is a common health problem among travelers visiting tropical and less developed countries and children living in those countries.
The US Navy seeks to commercialize through patent licensing a pharmaceutical to replace blood volume, promote tissue oxygenation, and encourage clotting in patients suffering from severe blood loss in pre-hospital emergencies.
The US Army seeks to commercialize through patent licensing a rapid whole blood assay to measure the activity of both acetylcholinesterase (AChE) and butylcholinesterase (BChE).
The US Naval Medical Research Center (NMRC), in partnership with the University of Guelph, seeks to commercialize through patent licensing a vaccine for use against Campylobacter jejuni.
The US Army seeks industry partners to license and commercialize an advanced point-of-care system optimized for integration within an overall enterprise management system for the healthcare market.
The United States Navy seeks industry partners to license and commercialize an advanced Calorimeter design that provides a top loaded twin cell with a removable reference. The advance Calorimeter design allows for the quick change of reference samples in a high density platform. This design provides advanced data measurement capabilities for faster and more accurate heat flow and thermal analysis of chemical reactions for material design.
The US Army seeks partners to license and commercialize a broad suite of hantavirus technologies based on DNA plasmid technologies